Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis: A Randomised Controlled Trial: The NORSEMAN Study

NCT05740722 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT05740722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05740722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis: A Randomised Controlled Trial: The NORSEMAN Study
Lead sponsor
Haukeland University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
May 3, 2023
Completion date
December 30, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, progressive multiple sclerosis